FDA approves dostarlimab (Jemperli) for certain patients with locally advanced rectal cancer
1. Interim results from the phase 2 AZUR-1 trial have demonstrated that at a median follow-up of 2 years. nearly ...
1. Interim results from the phase 2 AZUR-1 trial have demonstrated that at a median follow-up of 2 years. nearly ...
1. All neoadjuvant dostarlimab patients had a clinical complete response and no patients needed any additional treatments at the study ...
3-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
Monthly plan selected: $4.99 /month.
3-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
Yearly plan selected: $49.90 /year.
2 months free
Then $49.90/year.
Already a member? Sign in